Kiltearn Partners’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.37M Sell
90,550
-17,800
-16% -$733K 0.91% 23
2025
Q4
$5.07M Sell
108,350
-21,600
-17% -$934K 1.1% 26
2025
Q3
$5.44M Sell
129,950
-9,000
-6% -$396K 1.09% 28
2025
Q2
$6.12M Sell
138,950
-9,800
-7% -$444K 1.23% 26
2025
Q1
$7.49M Sell
148,750
-25,900
-15% -$1.28M 1.43% 23
2024
Q4
$7.5M Sell
174,650
-20,600
-11% -$869K 1.24% 29
2024
Q3
$7.66M Sell
195,250
-11,650
-6% -$421K 1.04% 28
2024
Q2
$6.66M Buy
+206,900
New +$6.67M 0.81% 31

Other funds holding G

Kiltearn Partners's G Position: Q1 2026 in Review

Kiltearn Partners reduced its Genpact (G) stake by 16% in Q1 2026, selling an estimated $733K and leaving 90,550 shares worth $3.37M. The position accounts for 0.91% of the portfolio, ranked #23.

Kiltearn Partners first reported a position in G in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.66M in Q3 2024. 516 funds tracked by Wall St. Rank hold G as of Q1 2026.

  • Kiltearn Partners held 90,550 shares of Genpact worth $3.37M as of Q1 2026.
  • Kiltearn Partners sold 17,800 Genpact shares in Q1 2026, an estimated $733K.
  • Genpact made up 0.91% of Kiltearn Partners's portfolio in Q1 2026, its #23 holding.
  • Kiltearn Partners first reported a position in Genpact in Q2 2024 and has held it in 8 quarters since.
  • Kiltearn Partners's Genpact position peaked at $7.66M in Q3 2024.
  • 516 funds tracked by Wall St. Rank held Genpact as of Q1 2026.

Based on Kiltearn Partners's 13F filing for Q1 2026, filed 14 May 2026.